VITAS Healthcare Expands Hospital-Based Inpatient Hospice Center Chemed Corp. (NYSE: CHE) VITAS Healthcare recently expanded its inpatient hospice care unit at the Florida-based Broward Health Medical Center. The inpatient facility now has 12 patient beds, up from eight prior to the renovations. VITAS expects to serve roughly 550 patients annually at the center. “VITAS is […]
ProMedica
Private equity firms typically turn around and sell an asset within three to five years post-acquisition. However, some may slow that cycle down in today’s economic environment. The presence of private equity firms in the hospice arena has expanded exponentially during the past several years. But this year, deal volume slowed across the board. While […]
A rich mix of hospice merger and acquisition (M&A) activity at the end of 2023 is fueling trends into next year. Hospice M&A activity has diverged from the frenzied pace set in recent years. The hospice space in the last five years has seen record-breaking multiples, a prevalence of private equity-backed platform transactions and large-scale […]
ProMedica Shutters Two Home Health Locations ProMedica is shuttering two home health and hospice programs in Ohio and Michigan. The closures will take effect in November. The closures are part of the nonprofit health system’s strategic plans to divest its home health care services, the company indicated in a letter penned to the Ohio Department […]
Hospice of Northwest Ohio is buying the operations of ProMedica Ebeid Hospice Residence. Terms of the transaction, expected to close on or before Oct. 31, were not disclosed. ProMedica’s Ebeid Hospice Residence is a 12-bed inpatient facility that opened in 2008, attached to ProMedica’s Flower Hospital campus. Ebeid offers short-term care for hospice patients with […]
Thus far in 2023, hospice merger and acquisition activity has deviated from prior years. This year is distinctive because of factors such as valuations, asset sizes and the mix of buyers. A number of trends have shifted. The last five years saw record-breaking multiples in the hospice space and private equity-backed platform deals were among […]
Regulatory challenges have contributed to the hospice sector’s current M&A slump, but this year’s volume nevertheless aligns with experts’ forecasts. In addition to those pressures, the industry is also in a cooling period in which companies focus on integrating the assets that many acquired during flurries of activity in 2021 and 2022, according to Mark […]
Hospice of the Chesapeake Appoints New CMO Maryland-based Hospice of the Chesapeake recently named Dr. Marny Fetzer as its new chief medical officer. Fetzer is currently system medical director for palliative care and hospice services at Illinois-based Ascension Health. She will step into the role at Hospice of the Chesapeake in July, alongside seeking a […]
Hospice merger and acquisition activity has taken a downturn in 2023, which is in line with projections from M&A experts. Approximately 14 hospice, home care and home health transactions were reported during the first quarter of 2023, according to recent data from Mertz Taggart. Less than a handful (about 4 or 5) of these were […]
Hospice transaction activity has plummeted to its lowest level in years, new dealmaking data suggests. That’s no surprise, as many anticipate health care investors to operate with a more conservative approach in 2023. The cooldown, experts note, is partly due to inflation reaching multi-decade highs, uncertainty in the banking world and credit markets drying up. […]